Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Translational Psychiatry
|
February 1, 2017
The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review
T Dahoun, S V Trossbach, N J Brandon, et al.
Current Pharmaceutical Design
|
August 20, 2009
Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging
O D Howes, A Egerton, V Allan, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 3, 2004
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia
A M Meaney, S Smith, O D Howes, et al.
Psychological Medicine
|
September 15, 2010
A comprehensive review and model of putative prodromal features of bipolar affective disorder
O D Howes, S Lim, G Theologos, et al.
Translational Psychiatry
|
June 13, 2019
Correction: Regulation of dopaminergic function: An [<sup>18</sup>F]-DOPA PET apomorphine challenge study in humans
S Jauhar, M Veronese, M Rogdaki, et al.
Translational Psychiatry
|
September 2, 2018
Correction: Regulation of dopaminergic function: an [<sup>18</sup>F]-DOPA PET apomorphine challenge study in humans
S Jauhar, M Veronese, M Rogdaki, et al.
Psychopharmacology
|
December 16, 2015
Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications
T A Pollak, K Beck, S R Irani, et al.
Translational Psychiatry
|
February 8, 2017
Regulation of dopaminergic function: an [<sup>18</sup>F]-DOPA PET apomorphine challenge study in humans
S Jauhar, M Veronese, M Rogdaki, et al.
Molecular Psychiatry
|
March 15, 2017
The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
A H Ashok, T R Marques, S Jauhar, et al.
Acta Psychiatrica Scandinavica
|
September 10, 2014
The practical management of refractory schizophrenia--the Maudsley Treatment REview and Assessment Team service approach
K Beck, R McCutcheon, M A P Bloomfield, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Translational Psychiatry
|
February 1, 2017
The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review
T Dahoun, S V Trossbach, N J Brandon, et al.
Current Pharmaceutical Design
|
August 20, 2009
Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging
O D Howes, A Egerton, V Allan, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 3, 2004
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia
A M Meaney, S Smith, O D Howes, et al.
Psychological Medicine
|
September 15, 2010
A comprehensive review and model of putative prodromal features of bipolar affective disorder
O D Howes, S Lim, G Theologos, et al.
Translational Psychiatry
|
June 13, 2019
Correction: Regulation of dopaminergic function: An [<sup>18</sup>F]-DOPA PET apomorphine challenge study in humans
S Jauhar, M Veronese, M Rogdaki, et al.
Translational Psychiatry
|
September 2, 2018
Correction: Regulation of dopaminergic function: an [<sup>18</sup>F]-DOPA PET apomorphine challenge study in humans
S Jauhar, M Veronese, M Rogdaki, et al.
Psychopharmacology
|
December 16, 2015
Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications
T A Pollak, K Beck, S R Irani, et al.
Translational Psychiatry
|
February 8, 2017
Regulation of dopaminergic function: an [<sup>18</sup>F]-DOPA PET apomorphine challenge study in humans
S Jauhar, M Veronese, M Rogdaki, et al.
Molecular Psychiatry
|
March 15, 2017
The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment
A H Ashok, T R Marques, S Jauhar, et al.
Acta Psychiatrica Scandinavica
|
September 10, 2014
The practical management of refractory schizophrenia--the Maudsley Treatment REview and Assessment Team service approach
K Beck, R McCutcheon, M A P Bloomfield, et al.
Page
of 3